LENZ Therapeutics, Inc. (LENZ)
9.07
-0.22
(-2.37%)
USD |
NASDAQ |
Apr 10, 16:00
9.06
-0.01
(-0.11%)
After-Hours: 20:00
LENZ Therapeutics Shareholders Equity (Quarterly) : 284.34M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.278M |
| Liminatus Pharma, Inc. | -9.815M |
| Oruka Therapeutics, Inc. | 471.93M |
| Maze Therapeutics, Inc. | 354.97M |
| MapLight Therapeutics, Inc. | 458.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 305.88M |
| Total Liabilities (Quarterly) | 21.54M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | 0.03% |